A retrospective analysis of high-risk patients for mediastinoscopy

被引:0
|
作者
Bulgen, Sibel Buluc [1 ]
Salihoglu, Ziya [1 ]
Demirkaya, Ahmet [2 ]
Yuceyar, Lale [1 ]
机构
[1] Istanbul Univ, Cerrahpasa Tip Fak, Anesteziyol & Reanimasyon Anabilim Dali, TR-34098 Istanbul, Turkey
[2] Istanbul Univ, Cerrahpasa Tip Fak, Gogus Cerrahisi Anabilim Dali, TR-34098 Istanbul, Turkey
关键词
Anesthesia; mediastinoscopy; thoracic surgery; LUNG-CANCER; COMPLICATIONS;
D O I
10.5606/tgkdc.dergisi.2013.6931
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: This study aims to investigate possible factors influencing mortality and morbidity rates in high-risk patients for mediastinoscopy. Methods: Between January 2006 and January 2011, 216 patients (54 females, 162 males; mean age 60.8 +/- 9.9 years; range 30 to 85 years) who underwent mediastinoscopy under general anesthesia in Istanbul University, Cerrahpasa Faculty of Medicine, Department of Thoracic Surgery were included. Date of surgery, duration of surgery, amount of intraoperative bleeding, amount of blood transfusion, postoperative hemoglobin level, type of surgery, diagnostic or staging technique, thoracotomy following mediastinoscopy, postoperative complications, the length of hospital stay, hospitalization in the intensive care unit and mortality in the intensive care unit and clinic were recorded by examining the medical records and medical files of the patients, anesthesiology follow-up forms and nurse observation charts. Results: The most common postoperative complications were sepsis, respiratory and cardiovascular system problems. Comorbidities including diabetes mellitus and cardiovascular diseases and smoking in patients aged >= 50 years were particularly associated with higher mortality and morbidity rates. Conclusion: We suggest that mediastinoscopy with an experienced surgical team, smoking cessation four to six weeks before surgery and a thorough identification of risk factors before surgery may decrease the mortality and morbidity rates.
引用
收藏
页码:699 / 705
页数:7
相关论文
共 50 条
  • [31] Are patients with high-risk polycythemia vera receiving cytoreductive medications? A retrospective analysis of real-world data
    Dilan Paranagama
    Philomena Colucci
    Kristin A. Evans
    Machaon Bonafede
    Shreekant Parasuraman
    Experimental Hematology & Oncology, 7
  • [32] Are patients with high-risk polycythemia vera receiving cytoreductive medications? A retrospective analysis of real-world data
    Paranagama, Dilan
    Colucci, Philomena
    Evans, Kristin A.
    Bonafede, Machaon
    Parasuraman, Shreekant
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2018, 7
  • [33] Cryosurgery for high-risk patients
    不详
    PROSTATE CANCER AND PROSTATIC DISEASES, 2005, 8 (02) : 105 - 105
  • [34] ANESTHESIA IN HIGH-RISK PATIENTS
    不详
    PATIENT CARE, 1974, 8 (07) : 169 - 169
  • [35] THROMBOLYSIS IN HIGH-RISK PATIENTS
    MCCALL, J
    GLEESON, FV
    MCGANN, G
    DAWSON, K
    PLATTS, AD
    HAMILTON, G
    CLINICAL RADIOLOGY, 1992, 45 (05) : 298 - 301
  • [36] ISOLATION FOR HIGH-RISK PATIENTS
    EMOND, RTD
    POSTGRADUATE MEDICAL JOURNAL, 1976, 52 (611) : 563 - 566
  • [37] Statins and High-Risk Patients
    Green, Patrick
    Battersby, Christopher
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2017, 224 (05) : 998 - 999
  • [38] Where are the high-risk patients?
    Useini, Dritan
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2021, 60 (06) : 1478 - 1478
  • [39] Management in High-risk Patients
    Burns, Patrick
    Highlander, Pete
    Shinabarger, Andrew B.
    CLINICS IN PODIATRIC MEDICINE AND SURGERY, 2014, 31 (04) : 523 - +
  • [40] Management for "high-risk" patients
    Harano, Kenichi
    ANNALS OF ONCOLOGY, 2016, 27